ArticleFrontiers in microbiology2018
Detection of Antilisterial Activity of 3-Phenyllactic Acid Using
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 41 citations in OpenAlex.
- Transcriptome analysis suggests the cell wall as the primary target of the antilisterial effect of carrots.Microbiology spectrum · 2026Article
- Mixed-species biofilms in food systems: from community assembly to ecology-informed management.Frontiers in microbiology · 2026Review
- Structural properties of short-chain carboxylic acids and alcohols relate to the molecular and physiological response of Salmonella enterica in an acidic environment.Applied microbiology and biotechnology · 2025Article
- Antibacterial and Antibiofilm Efficacy of Phenyllactic Acid Against Foodborne PathogensMolecules (Basel, Switzerland) · 2025Article
- Integrated Biotechnological Strategies for the Sustainability and Quality of Mediterranean Sea Bass (Foods (Basel, Switzerland) · 2025Review
- Edible Insect Meals as Bioactive Ingredients in Sustainable Snack Bars.Foods (Basel, Switzerland) · 2025Article
- Investigating the Potential of L(+)-Lactic Acid as a Green Inhibitor and Eradicator of a Dual-SpeciesMicroorganisms · 2024Article
- Antimicrobial activity of phenyllactic acid against Klebsiella pneumoniae and its effect on cell wall membrane and genomic DNA.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
- Anti-Biofilm Activity of Phenyllactic Acid against Clinical Isolates of Fluconazole-ResistantJournal of fungi (Basel, Switzerland) · 2023Article
- Comprehensive analysis of metabolites produced by co-cultivation ofFrontiers in microbiology · 2023Article
- Review
- Fungi Occurrence in Ready-to-Eat Hazelnuts (Frontiers in microbiology · 2022Article
- Bioprospecting Antimicrobials fromInternational journal of molecular sciences · 2021Review
- Article
- Probiotic Properties and Potentiality ofJournal of fungi (Basel, Switzerland) · 2021Article
- Using Unnatural Protein Fusions to Engineer a Coenzyme Self-Sufficiency System for D-Phenyllactic Acid Biosynthesis inFrontiers in bioengineering and biotechnology · 2021Article
- Combinational Antibacterial Activity of Nisin and 3-Phenyllactic Acid and Their Co-production by EngineeredFrontiers in bioengineering and biotechnology · 2021Article
- Potential Application ofFoods (Basel, Switzerland) · 2020Article
- Bio-inspired facile fabrication of silver nanoparticles fromRSC advances · 2020Article
- Antimicrobial Activity againstAntibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 3-Phenyllactic acid (PLA) produced by various lactic acid bacteria (LAB) possesses a broad spectrum of antimicrobial activity. In this study, the effect of PLA against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.